No primary association between the 308 polymorphism in the tumor necrosis factor α promoter region and insulin-dependent diabetes mellitus

Human Immunology

Volumn 45, Issue 2, 1996, Pages 137-142

  Deng, Glenn Y ^a   Maclaren, Noel K ^a   Huang, Hong So ^b   Zhang, Li Ping ^a   She, Jin Xiong ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR;

EID: 0029996311     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/0198-8859(95)00166-2     Document Type: Article

References (38)

1. Diabetes Epidemiology Research International Group: Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes 37:1113, 1988.
2. Todd JA: A protective role of the environment in the development of type I diabetes? Diabetic Med 8:906, 1991.
3. Davies JL, Yoshihiko K, Bennett S, et al: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371:130, 1994.
4. Hashimoto L, Habita C, Beressi JP, et al: Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 371:161, 1994.
5. Field LL, Tobias R, Magnus T: A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus. Nature Genetics 8:189, 1994.
6. Owerbach D, Gabbay KH: The HOXD8 locus (2q31) is linked to type I diabetes: interaction with chromosome 6 and 11 disease susceptibility genes. Diabetes 44:132, 1995.
7. Luo DF, Bui MM, Muir A, Maclaren NK, Thomson G, She JX: Affected sibpair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am J Hum Genet 57:911, 1995.
8. Copeman JB, Cucca F, Hearne CM, et al: Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nature Genetics 9:80, 1995.
9. Tiwari JL, Terasaki PI: Endocrinology. In Tiwari JL, Terasaki PI (eds): HLA and Disease Associations. New York, Springer-Verlag, 1985, p 185.
10. Owerbach D, Gunn S, Gabbay KH: Primary association of HLA-DQwS with type I diabetes in DR4 patients. Diabetes 38:942, 1989.
11. Thorsby E, Ronningen KS: Role of HLA genes in predisposition to develop insulin-dependent diabetes mellitus. Ann Med 24:523, 1992.
12. Thorsby E, Ronningen KS: Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:371, 1993.
13. Dick LR, Aldrich C, Jameson SC, et al: proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to yield antigenic peptides. J Immunol 152: 3884, 1994.
14. Driscoll J, Brown MG, Finley D, Monaco JJ: MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365:262, 1993.
15. Gaczynska M, Rock KL, Goldberg AL: Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365:264, 1993.
16. Fehling HJ, Swat W, Laplace C, et al: MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265:1234, 1994.
17. Deng GY, Muir A, Maclaren NK, She JX: Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Am J Hum Genet 56:528, 1995.
18. Caillat-Zucman S, Bertin E, Timsit J, Boitard C, Assan R, Bach JF: Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene. Eur J Immunol 23:1784, 1993.
19. Pujol-Borrell R, Todd I, Doshi M, et al: HLA class II induction in human islet cells by interferon-gamma plus tumor necrosis factor or lymphotoxin. Nature 326:304, 1987.
20. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D: Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371:508, 1994.
21. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87:1233, 1990.
22. Jacob CO: Tumor necrosis factor α in autoimmunity: pretty girl or old witch? Immunol Today 13:122, 1992.
23. Jacob CO, McDevitt HO: Tumor necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature 331:356, 1988.
24. Bendtzen K, Morling N, Fomsgaard A, et al: Association between HLA-DR2 and production of tumor necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scan J Immunol 28:599, 1988.
25. Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M: Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232:1545, 1986.
26. Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J: Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. J Immunol 139:4077, 1987.
27. Bendtzen K: Immune hormones (cytokines): pathogenic role in autoimmune rheumatic and endocrine diseases. Autoimmunity 2:177, 1989.
28. Badenhoop K, Schwarz G, Trowsdale J, et al: TNF-alpha gene polymorphism in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 32:445, 1989.
29. Badenhoop K, Schwarz G, Bingley P, et al: TNF-alpha gene polymorphisms: association with type 1 (insulin-dependent) diabetes mellitus. J Immunogenet 1995.
30. Pociot F, Molvig J, Wogensen L, et al: A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scan J Immunol 33:37, 1991.
31. Pociot F, Wilson AG, Nerup J, Duff GW: No independent association between a tumor necrosis factor-α promoter region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 23:3043, 1993.
32. Maclaren N, Riley W, Skordis N, et al: Inherited susceptibility to IDD is associated with HLA-DR1, while DR5 is protective. Autoimmunity 1:197, 1988.
33. Huang W, She JX, Muir A, et al: High risk HLA-DR/DQ genotypes for IDD confer susceptibility to autoantibodies but DQB1*0602 does not prevent them. J Autoimmunity 7:889, 1994.
34. She JX, Bui MM, Tian XH, et al: Additive susceptibility to insulin-dependent diabetes conferred by HLA-DQB1 and insulin genes. Autoimmunity 18:195, 1994.
35. Huang HS, Peng JT, She JY, et al: HLA-encoded susceptibility to IDDM is determined by DR and DQ genes as well as their linkage disequilibrium in a Chinese population. Hum Immunol 1995 (in press).
36. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW: An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177:557, 1993.
37. Tiwari JL, Terasaki PI: The data and statistical analysis. In Tiwari JL, Terasaki PI (eds): HLA and Disease Associations. New York, Springer Verlag, 1985, p 18.
38. Svejgaard A, Hauge M, Jersild C, et al: The HLA system; an introductory survey. Monogr Hum Genet 7:1, 1975.